文献速递乳腺MR

压缩感知超快速动态增强MRI早期动力学参数与乳腺癌预后因素的相关性

Ultrafast Dynamic Contrast-Enhanced MRI Using Compressed Sensing: Associations of Early Kinetic Parameters With Prognostic Factors of Breast Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2021-04-28

该研究纳入201例连续乳腺癌女性患者,评估压缩感知超快速DCE-MRI(时间分辨率4.7秒,空间分辨率0.8×1.1×0.9 mm)的早期动力学参数TTE和MS与组织病理预后因素的相关性。结果显示MS在浸润性癌中显著大于原位癌,肿瘤大小>2 cm和ER阴性状态与更短TTE相关,组织学分级3级与更大MS相关。超快速MRI早期强化参数与乳腺癌组织病理预后因素相关。

要点

  • 超快速DCE-MRI可测量TTE和MS,观察者间一致性优秀(ICC 0.943和0.890)。
  • 浸润性癌MS中位数8.4%/s显著高于原位癌的4.7%/s,有助鉴别。
  • 肿瘤>2 cm、ER阴性者TTE更短,组织学分级3级者MS更大。

核心结论

  • 超快速MRI衍生的早期强化参数TTE和MS与乳腺癌组织病理预后因素相关。

研究设计与样本

  • 单中心回顾性研究,纳入201例连续女性乳腺癌患者(平均年龄54.6岁,168例浸润性癌,33例导管原位癌)。
  • 所有患者于2018至2019年间接受压缩感知超快速DCE-MRI(时间分辨率4.7秒,空间分辨率0.8×1.1×0.9 mm)及手术。
  • 由两名放射科医生使用软件测量乳腺病灶的早期动力学参数TTE和MS,并与组织病理预后因素进行相关性分析。
  • 统计方法采用Mann-Whitney U检验和线性回归分析。

关键影像表现/征象

  • 乳腺癌病灶TTE中位数为11.9秒,MS中位数为7.7%/s。
  • 浸润性癌MS中位数显著大于导管原位癌(8.4%/s vs 4.7%/s,p < .001)。
  • 两名读者测量TTE和MS的观察者间一致性优秀,组内相关系数分别为0.943和0.890。

诊断标准与关键数值

  • TTE中位数11.9秒、MS中位数7.7%/s为乳腺癌总体参考值。
  • 浸润性癌MS中位数8.4%/s,导管原位癌MS中位数4.7%/s(p < .001)。
  • 浸润性癌中,肿瘤大小>2 cm(p = .048)和ER阴性(p < .001)与更短TTE显著相关。
  • 浸润性癌中,组织学分级3级(p = .01)与更大MS显著相关。
  • TTE和MS的观察者间ICC分别为0.943和0.890。

临床应用与阅片要点

  • 超快速DCE-MRI的TTE和MS可在术前无创提示乳腺癌预后因素,辅助风险分层。
  • MS较高提示浸润性癌可能,MS较低(如约4.7%/s)需考虑导管原位癌。
  • TTE缩短(<11.9秒)伴肿瘤>2 cm或ER阴性时,应警惕更具侵袭性的生物学行为。
  • 测量TTE和MS具有优秀可重复性,适合纳入乳腺MRI结构化报告。

局限性

  • 单中心回顾性研究,结论外推需多中心验证。
  • 样本仅来自2018至2019年连续病例,可能存在选择偏倚。
  • 原文未报告TTE和MS的诊断阈值、敏感度、特异度或AUC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to investigate whether early kinetic parameters derived from ultrafast dynamic contrast-enhanced MRI (DCE-MRI) using compressed sensing are associated with prognostic factors for breast cancer. MATERIALS AND METHODS. We evaluated 201 consecutive women (mean age, 54.6 years) with breast cancer (168 invasive, 33 ductal carcinoma in situ) who underwent both ultrafast DCE-MRI using compressed sensing (temporal resolution, 4.7 seconds; spatial resolution, 0.8 × 1.1 × 0.9 mm) and surgery between 2018 and 2019. Early kinetic parameters (time to enhancement [TTE] and maximum slope [MS]) were measured in breast lesions by two radiologists using a software program and were correlated with histopathologic prognostic factors. The Mann-Whitney U test and linear regression analysis were used. RESULTS. The median TTE and MS values for breast cancer were 11.9 seconds and 7.7%/s, respectively. The median MS was significantly larger in invasive cancer lesions than in ductal carcinoma in situ lesions (8.4%/s vs 4.7%/s, p < .001). In women with invasive cancer, multivariate linear regression analyses showed that a larger tumor size (> 2 cm) (p = .048) and estrogen receptor-negative status (p < .001) were significantly associated with a shorter TTE. A higher histologic grade (grade 3) (p = .01) was significantly associated with a larger MS. We observed excellent interobserver agreement between two readers in the measurements of TTE and MS (intraclass correlation coefficients, 0.943 and 0.890, respectively). CONCLUSION. Ultrafast MRI-derived early enhancement parameters, such as TTE and MS, are associated with histopathologic prognostic factors in women with breast cancer.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kim JJ, Kim JY, Hwangbo L, et al. Ultrafast Dynamic Contrast-Enhanced MRI Using Compressed Sensing: Associations of Early Kinetic Parameters With Prognostic Factors of Breast Cancer. AJR Am J Roentgenol. 2021. PMID: 33909465. doi:10.2214/AJR.20.23457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。